Kenta Kawahara

2.4k total citations
75 papers, 1.7k citations indexed

About

Kenta Kawahara is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kenta Kawahara has authored 75 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 22 papers in Molecular Biology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kenta Kawahara's work include Head and Neck Cancer Studies (13 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cancer-related molecular mechanisms research (7 papers). Kenta Kawahara is often cited by papers focused on Head and Neck Cancer Studies (13 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cancer-related molecular mechanisms research (7 papers). Kenta Kawahara collaborates with scholars based in Japan, United States and France. Kenta Kawahara's co-authors include Keiko Tsuruda, Hideki Nakayama, Ryoji Yoshida, Masashi Nagata, Masanori Shinohara, Akiyuki Hirosue, Akimitsu Hiraki, Yuichiro Matsuoka, Takuya Tanaka and Junki Sakata and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Kenta Kawahara

69 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenta Kawahara Japan 22 552 464 363 314 282 75 1.7k
Wencheng Zhang China 28 627 1.1× 402 0.9× 540 1.5× 593 1.9× 163 0.6× 152 2.0k
Kai Xu China 25 513 0.9× 346 0.7× 278 0.8× 144 0.5× 180 0.6× 119 1.7k
Hiroshi Kajiwara Japan 24 358 0.6× 379 0.8× 236 0.7× 342 1.1× 243 0.9× 131 1.7k
Hiroyuki Kumamoto Japan 33 1.1k 2.1× 598 1.3× 119 0.3× 496 1.6× 148 0.5× 138 2.7k
Anna Patrikidou France 23 359 0.7× 761 1.6× 924 2.5× 412 1.3× 366 1.3× 82 2.2k
Jung‐Hoon Park South Korea 23 280 0.5× 298 0.6× 736 2.0× 935 3.0× 94 0.3× 181 2.0k
Fumio Ide Japan 30 933 1.7× 630 1.4× 215 0.6× 696 2.2× 272 1.0× 188 3.4k
Thomas Ziebart Germany 29 603 1.1× 948 2.0× 139 0.4× 317 1.0× 176 0.6× 76 2.3k
Abraham Schneider United States 28 1.1k 1.9× 1.4k 3.1× 399 1.1× 303 1.0× 294 1.0× 73 3.3k
Yi Xiang China 25 602 1.1× 501 1.1× 522 1.4× 244 0.8× 242 0.9× 59 2.0k

Countries citing papers authored by Kenta Kawahara

Since Specialization
Citations

This map shows the geographic impact of Kenta Kawahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenta Kawahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenta Kawahara more than expected).

Fields of papers citing papers by Kenta Kawahara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenta Kawahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenta Kawahara. The network helps show where Kenta Kawahara may publish in the future.

Co-authorship network of co-authors of Kenta Kawahara

This figure shows the co-authorship network connecting the top 25 collaborators of Kenta Kawahara. A scholar is included among the top collaborators of Kenta Kawahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenta Kawahara. Kenta Kawahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirosue, Akiyuki, Misaki Matsuo, Haruki Saito, et al.. (2025). Robust HPV‐16 Detection Workflow for Formalin‐Fixed Cancer Tissue and Its Application for Oral Squamous Cell Carcinoma. Cancer Medicine. 14(4). e70544–e70544.
2.
Matsuoka, Yuichiro, Hiromu Yano, Tatsuro Yamamoto, et al.. (2024). Involvement of ferroptosis‐defensive xCT/GPX4 axis in radioresistance and its impacts on prognosis in oral squamous cell carcinoma. Oral Science International. 21(3). 359–372. 1 indexed citations
3.
Kawahara, Kenta, Akimitsu Hiraki, Hidetaka Arita, et al.. (2020). Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy. Oral Diseases. 27(6). 1564–1571. 5 indexed citations
4.
Sakata, Junki, Akiyuki Hirosue, Ryoji Yoshida, et al.. (2020). Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma. Cancers. 12(2). 494–494. 8 indexed citations
5.
Yoshida, Ryoji, Masashi Nagata, Akiyuki Hirosue, et al.. (2020). Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method. PLoS ONE. 15(4). e0231656–e0231656. 2 indexed citations
6.
Sakata, Junki, Akiyuki Hirosue, Ryoji Yoshida, et al.. (2019). HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 20(10). 2473–2473. 34 indexed citations
7.
Kawahara, Kenta, Akimitsu Hiraki, Ryoji Yoshida, et al.. (2017). Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report. Molecular and Clinical Oncology. 6(6). 886–892. 10 indexed citations
8.
Hiraki, Akimitsu, Takaya Yamamoto, Ryoji Yoshida, et al.. (2016). Factors affecting volume change of myocutaneous flaps in oral cancer. International Journal of Oral and Maxillofacial Surgery. 45(11). 1395–1399. 15 indexed citations
9.
Nakashima, Hikaru, Yuichiro Matsuoka, Ryoji Yoshida, et al.. (2016). Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study. BMC Cancer. 16(1). 41–41. 47 indexed citations
10.
Yoshitake, Yoshihiro, Daiki Fukuma, Akira Yuno, et al.. (2014). Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS. Clinical Cancer Research. 21(2). 312–321. 123 indexed citations
11.
Nagata, Masashi, Yoshihiro Yoshitake, Hideki Nakayama, et al.. (2014). Angiosarcoma of the oral cavity: a clinicopathological study and a review of the literature. International Journal of Oral and Maxillofacial Surgery. 43(8). 917–923. 19 indexed citations
12.
Nakamura, Takuya, Satoru Shinriki, Hirofumi Jono, et al.. (2014). Osteopontin‐integrin αvβ3 axis is crucial for 5‐fluorouracil resistance in oral squamous cell carcinoma. FEBS Letters. 589(2). 231–239. 15 indexed citations
13.
Nakagawa, Yoshihiro, Hideki Nakayama, Masashi Nagata, et al.. (2014). Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells. International Journal of Oncology. 44(4). 1376–1384. 47 indexed citations
14.
Tomita, Yusuke, Akira Yuno, Hirotake Tsukamoto, et al.. (2013). Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor. Clinical Cancer Research. 19(16). 4508–4520. 50 indexed citations
15.
Takeno, Shinsuke, Yoshiaki Takahashi, Takashi Hashimoto, et al.. (2013). Is the Prognostic Impact of Tumor Location in Patients with<b> </b>Surgically Resected Esophageal Squamous Cell Carcinoma Affected by Surgical Approach?. European Surgical Research. 51(1-2). 91–98. 4 indexed citations
16.
Tanaka, Takuya, Hideki Nakayama, Yoshihiro Yoshitake, et al.. (2011). Selective inhibition of nuclear factor‐κB by nuclear factor‐κB essential modulator‐binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma. Cancer Science. 103(3). 455–463. 23 indexed citations
17.
Masuda, Yoshiko, Naoko Yoshida, H Matsuzaki, et al.. (2007). p53AIP1 Expression can be a Prognostic Marker in Non-small Cell Lung Cancer. Clinical Oncology. 20(2). 148–151. 14 indexed citations
18.
Kawahara, Kenta, et al.. (2000). Antibacterial effect of silver-zeolite on oral bacteria under anaerobic conditions. Dental Materials. 16(6). 452–455. 327 indexed citations
19.
Kawahara, Kenta, Takafumi Maekawa, Kan Okabayashi, et al.. (1999). Video-assisted thoracoscopic esophagectomy for esophageal cancer. Surgical Endoscopy. 13(3). 218–223. 87 indexed citations
20.
Fukuda, Masamichi, et al.. (1993). White matter change on CT associated with superior vena cava syndrome: A case report. Pediatric Radiology. 23(1). 53–54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wencheng Zhang Breakdown of academic impact, for papers by Kai Xu Breakdown of academic impact, for papers by Hiroshi Kajiwara Breakdown of academic impact, for papers by Hiroyuki Kumamoto Breakdown of academic impact, for papers by Anna Patrikidou Breakdown of academic impact, for papers by Jung‐Hoon Park Breakdown of academic impact, for papers by Fumio Ide Breakdown of academic impact, for papers by Thomas Ziebart Breakdown of academic impact, for papers by Abraham Schneider Breakdown of academic impact, for papers by Yi Xiang
Rankless by CCL
2026